Neuren Pharmaceuticals Limited (ASX:NEU)
Australia · Delayed Price · Currency is AUD 16.97
-0.54 (-3.08%)
Jul 17, 2026, 4:10 PM AEST
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of 2.14 billion as of July 17, 2026. Its market cap has increased by 16.67% in one year.
Market Cap
2.14B
Enterprise Value
1.85B
Revenue
64.65M
Ranking
n/a
PE Ratio
72.93
Stock Price
16.97
ChartMarket Cap Chart
Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 2.14B, an increase of 10,144.00%. That is a compound annual growth rate of 24.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 2.14B | -9.04% |
| Dec 31, 2025 | 2.36B | 48.44% |
| Dec 31, 2024 | 1.59B | -50.04% |
| Dec 29, 2023 | 3.18B | 217.33% |
| Dec 30, 2022 | 1.00B | 110.88% |
| Dec 31, 2021 | 474.89M | 222.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 5.07B |
| Mesoblast | 3.17B |
| PYC Therapeutics | 1.58B |
| Clarity Pharmaceuticals | 865.55M |
| Clinuvel Pharmaceuticals | 500.24M |
| Racura Oncology | 416.54M |
| Tetratherix | 358.12M |
| Starpharma Holdings | 299.02M |